Septra ds and Allergic rhinitis - a phase IV clinical study of FDA data

Summary:

Allergic rhinitis is reported as a side effect among people who take Septra ds (sulfamethoxazole; trimethoprim), especially for people who are female, 50-59 old, also take Compazine, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Allergic rhinitis when taking Septra ds. It is created by eHealthMe based on reports of 2,191 people who have side effects when taking Septra ds from the FDA, and is updated regularly.

What is Septra ds?

Septra ds has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 2,349 Septra ds users. Check the latest studies of Septra ds.

What is Allergic rhinitis?

Allergic rhinitis is found to be associated with 911 drugs and 1,314 conditions by eHealthMe. Check the latest studies of Allergic rhinitis.

On Jul, 20, 2026

2,191 people reported to have side effects when taking Septra ds.
Among them, 13 people (0.59%) have Allergic rhinitis.

Could Septra ds cause Allergic rhinitis?

Among these 13 people:

What is the gender of people who have Allergic rhinitis when taking Septra ds? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Allergic rhinitis when taking Septra ds? *

What are other drugs people take besides Septra ds? *

What are other side effects people have besides Allergic rhinitis? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 92.31%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 12 people, 92.31%
Insomnia (sleeplessness): 11 people, 84.62%
Back Pain: 11 people, 84.62%
Stress And Anxiety: 11 people, 84.62%
High Blood Pressure: 11 people, 84.62%
Rashes (redness): 11 people, 84.62%
Injury: 10 people, 76.92%
Arrhythmias (irregular heartbeat): 10 people, 76.92%
Swelling: 10 people, 76.92%

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 69.23%
Breast Cancer Metastatic: 7 people, 53.85%
Joint Pain: 2 people, 15.38%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 7.69%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.69%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Septra ds and have Allergic rhinitis?

- Check whether Allergic rhinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Septra ds:

Septra ds (2,349 reports)

Allergic rhinitis treatments and more:

Allergic rhinitis (20,443 reports)

How severe was Allergic rhinitis and when was it recovered:

Allergic rhinitis in Septra ds

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Allergic rhinitis and drugs with ingredients of sulfamethoxazole; trimethoprim (115 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Septra ds:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Allergic rhinitis:

Allergic rhinitis (911 drugs)

Browse all the conditions that are associated with Allergic rhinitis:

Allergic rhinitis (1,314 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Septra ds) and Septra ds (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.